Symbols / CNS Stock $68.27 -1.47% Cohen & Steers, Inc.
CNS (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Cohen & Steers, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides its services to institutional investors, including pension funds, endowments, and foundations. It manages separate client-focused equity, fixed income, multi-asset, and commodity portfolios through its subsidiaries. The firm launches and manages equity, fixed income, balanced, and multi-asset mutual funds through its subsidiaries. Through its subsidiaries, it also launches and manages hedge funds. The firm invests in public equity, fixed income, and commodity markets across the globe through its subsidiaries. Through its subsidiaries, it invests in companies operating in the real estate sector, including real estate investment trusts, infrastructure sector, and natural energy resources sector for its equity and fixed income investments. The firm also invests in preferred securities for its fixed income investments through its subsidiaries. The firm is a leading global investment manager specializing in real assets and alternative income, including real estate, preferred securities, infrastructure, resource equities, commodities, as well as multi-strategy solutions. Cohen & Steers, Inc. was founded in 1986 and is based in New York.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-04-10 | main | Evercore ISI Group | Outperform → Outperform | $75 |
| 2025-10-20 | main | Evercore ISI Group | Outperform → Outperform | $77 |
| 2025-10-09 | main | Evercore ISI Group | Outperform → Outperform | $74 |
| 2025-10-02 | main | B of A Securities | Underperform → Underperform | $68 |
| 2025-09-05 | main | Evercore ISI Group | Outperform → Outperform | $77 |
| 2025-07-21 | main | B of A Securities | Underperform → Underperform | $66 |
| 2025-06-30 | init | B of A Securities | — → Underperform | $67 |
| 2025-04-11 | main | Evercore ISI Group | Outperform → Outperform | $78 |
| 2024-11-07 | main | Evercore ISI Group | Outperform → Outperform | $111 |
| 2024-10-17 | up | UBS | Sell → Neutral | $102 |
| 2024-10-04 | main | Evercore ISI Group | Outperform → Outperform | $96 |
| 2024-09-05 | main | Evercore ISI Group | Outperform → Outperform | $92 |
| 2024-07-10 | main | UBS | Sell → Sell | $63 |
| 2024-04-12 | main | UBS | Sell → Sell | $67 |
| 2024-03-08 | main | Evercore ISI Group | Outperform → Outperform | $78 |
| 2024-01-10 | main | UBS | Sell → Sell | $69 |
| 2024-01-05 | init | UBS | — → Sell | $68 |
| 2023-04-13 | main | Evercore ISI Group | — → Outperform | $68 |
| 2020-11-19 | up | B of A Securities | Neutral → Buy | $76 |
| 2020-04-24 | up | B of A Securities | Underperform → Neutral | — |
News
RSS: Latest CNS news- Why is CNS Pharmaceuticals stock up 250% today? - Investing.com Mon, 04 May 2026 15
- Biotech CNS raises $22.5M to buy clinical-stage drug assets - Stock Titan Mon, 04 May 2026 11
- Why Is CNS Pharmaceuticals Stock (CNSP) Up Today? - TipRanks Mon, 04 May 2026 14
- Nano-Cap CNS Pharmaceuticals Stock Explodes As Capital Raise Fuels Pivot - Benzinga Mon, 04 May 2026 13
- Why CNS Pharmaceuticals (CNSP) Stock Is Up 215% Today - CoinCentral Mon, 04 May 2026 14
- Trending Stocks Today | CNS Pharmaceuticals Soars 280.77% - Moomoo Mon, 04 May 2026 14
- CNS Pharmaceuticals (CNSP) Stock Skyrockets 215% on $22.5M Fundraise - MEXC Mon, 04 May 2026 19
- Fund Update: New $26.4M $CNS stock position opened by DAVENPORT & Co LLC - Quiver Quantitative Wed, 15 Apr 2026 07
- Cohen & Steers (CNS) shareholders back directors, auditor and pay plan - Stock Titan Mon, 04 May 2026 20
- Precision Trading with Cohen & Steers Inc (CNS) Risk Zones - Stock Traders Daily Fri, 01 May 2026 06
- CNS Pharmaceuticals (CNSP) Stock Skyrockets 215% on $22.5M Funding Round - Blockonomi Mon, 04 May 2026 15
- Cohen & Steers Shareholders Back Board and Governance - TipRanks Mon, 04 May 2026 21
- Why is CNS Pharmaceuticals stock up 250% today? By Investing.com - Investing.com UK Mon, 04 May 2026 15
- A $20M Lunai deal adds two routes past the blood-brain barrier - Stock Titan Mon, 04 May 2026 13
- CNS Pharmaceuticals (NASDAQ: CNSP) completes $22.5M private placement and board change - Stock Titan Mon, 04 May 2026 11
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
578.12
+7.71%
|
536.76
+6.45%
|
504.25
-12.11%
|
573.72
|
| Operating Revenue |
|
576.18
+7.79%
|
534.54
+6.43%
|
502.23
-12.08%
|
571.22
|
| Cost Of Revenue |
|
297.36
+8.08%
|
275.12
+8.16%
|
254.35
-12.82%
|
291.76
|
| Reconciled Cost Of Revenue |
|
295.43
+8.12%
|
273.24
+7.86%
|
253.31
-12.79%
|
290.48
|
| Gross Profit |
|
280.76
+7.31%
|
261.64
+4.70%
|
249.90
-11.37%
|
281.96
|
| Operating Expense |
|
81.02
+16.70%
|
69.42
-1.96%
|
70.81
+19.59%
|
59.21
|
| Selling General And Administration |
|
71.23
+18.46%
|
60.13
-9.85%
|
66.70
+21.66%
|
54.83
|
| General And Administrative Expense |
|
71.23
+18.46%
|
60.13
-9.85%
|
66.70
+21.66%
|
54.83
|
| Other Gand A |
|
71.23
+18.46%
|
60.13
-9.85%
|
66.70
+21.66%
|
54.83
|
| Total Expenses |
|
378.38
+9.82%
|
344.54
+5.96%
|
325.16
-7.35%
|
350.97
|
| Operating Income |
|
199.75
+3.91%
|
192.22
+7.33%
|
179.09
-19.60%
|
222.76
|
| Total Operating Income As Reported |
|
177.74
+2.81%
|
172.88
+5.11%
|
164.48
-23.83%
|
215.94
|
| EBITDA |
|
211.46
+3.97%
|
203.39
+10.40%
|
184.24
-19.34%
|
228.42
|
| Normalized EBITDA |
|
206.57
+11.02%
|
186.07
+1.63%
|
183.08
-28.00%
|
254.28
|
| Reconciled Depreciation |
|
11.71
+4.88%
|
11.17
+117.21%
|
5.14
-9.26%
|
5.67
|
| EBIT |
|
199.75
+3.91%
|
192.22
+7.33%
|
179.09
-19.60%
|
222.76
|
| Total Unusual Items |
|
4.88
-71.80%
|
17.32
+1398.27%
|
1.16
+104.47%
|
-25.86
|
| Total Unusual Items Excluding Goodwill |
|
4.88
-71.80%
|
17.32
+1398.27%
|
1.16
+104.47%
|
-25.86
|
| Net Income |
|
153.22
+1.29%
|
151.26
+17.22%
|
129.05
-24.55%
|
171.04
|
| Pretax Income |
|
204.63
-2.34%
|
209.54
+16.25%
|
180.25
-8.45%
|
196.90
|
| Net Non Operating Interest Income Expense |
|
—
|
—
|
14.62
+114.40%
|
6.82
|
| Net Interest Income |
|
—
|
—
|
14.62
+114.40%
|
6.82
|
| Interest Income Non Operating |
|
—
|
—
|
14.62
+114.40%
|
6.82
|
| Interest Income |
|
—
|
—
|
14.62
+114.40%
|
6.82
|
| Other Income Expense |
|
4.88
-71.80%
|
17.32
+1398.27%
|
1.16
+104.47%
|
-25.86
|
| Gain On Sale Of Security |
|
4.88
-71.80%
|
17.32
+1398.27%
|
1.16
+104.47%
|
-25.86
|
| Tax Provision |
|
47.23
+1.03%
|
46.75
+7.12%
|
43.64
-7.95%
|
47.41
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
-2.53%
|
0.00
+11.58%
|
0.00
|
| Tax Effect Of Unusual Items |
|
1.15
-71.80%
|
4.09
+1360.41%
|
0.28
+104.99%
|
-5.61
|
| Net Income Including Noncontrolling Interests |
|
157.40
-3.31%
|
162.79
+19.17%
|
136.61
-8.61%
|
149.49
|
| Net Income From Continuing Operation Net Minority Interest |
|
153.22
+1.29%
|
151.26
+17.22%
|
129.05
-24.55%
|
171.04
|
| Net Income From Continuing And Discontinued Operation |
|
153.22
+1.29%
|
151.26
+17.22%
|
129.05
-24.55%
|
171.04
|
| Net Income Continuous Operations |
|
157.40
-3.31%
|
162.79
+19.17%
|
136.61
-8.61%
|
149.49
|
| Minority Interests |
|
-4.18
+63.73%
|
-11.53
-52.47%
|
-7.56
-135.07%
|
21.56
|
| Normalized Income |
|
149.48
+8.30%
|
138.03
+7.69%
|
128.17
-33.00%
|
191.29
|
| Net Income Common Stockholders |
|
153.22
+1.29%
|
151.26
+17.22%
|
129.05
-24.55%
|
171.04
|
| Diluted EPS |
|
2.97
+0.00%
|
2.97
+14.23%
|
2.60
-25.07%
|
3.47
|
| Basic EPS |
|
2.99
-0.33%
|
3.00
+14.50%
|
2.62
-25.36%
|
3.51
|
| Basic Average Shares |
|
51.17
+1.51%
|
50.41
+2.23%
|
49.31
+1.08%
|
48.78
|
| Diluted Average Shares |
|
51.53
+1.15%
|
50.94
+2.79%
|
49.55
+0.52%
|
49.30
|
| Diluted NI Availto Com Stockholders |
|
153.22
+1.29%
|
151.26
+17.22%
|
129.05
-24.55%
|
171.04
|
| Depreciation Amortization Depletion Income Statement |
|
9.79
+5.36%
|
9.29
+126.26%
|
4.11
-6.34%
|
4.38
|
| Depreciation And Amortization In Income Statement |
|
9.79
+5.36%
|
9.29
+126.26%
|
4.11
-6.34%
|
4.38
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
876.69
+7.92%
|
812.37
+10.29%
|
736.55
+9.38%
|
673.38
|
| Current Assets |
|
392.54
+1.75%
|
385.79
+13.80%
|
339.00
+2.28%
|
331.46
|
| Cash Cash Equivalents And Short Term Investments |
|
310.89
+0.31%
|
309.93
+16.76%
|
265.44
+1.04%
|
262.71
|
| Cash And Cash Equivalents |
|
145.45
-20.51%
|
182.97
-2.38%
|
187.44
-24.24%
|
247.42
|
| Cash Financial |
|
—
|
—
|
187.44
-24.24%
|
247.42
|
| Other Short Term Investments |
|
165.44
+30.32%
|
126.95
+62.77%
|
78.00
+410.14%
|
15.29
|
| Receivables |
|
81.64
+7.62%
|
75.86
+3.12%
|
73.57
+7.00%
|
68.76
|
| Accounts Receivable |
|
79.78
+7.24%
|
74.39
+7.98%
|
68.89
+3.32%
|
66.68
|
| Other Receivables |
|
1.86
+26.53%
|
1.47
-68.48%
|
4.68
+124.86%
|
2.08
|
| Total Non Current Assets |
|
484.16
+13.50%
|
426.58
+7.30%
|
397.55
+16.27%
|
341.92
|
| Net PPE |
|
162.41
-3.21%
|
167.80
-1.08%
|
169.64
+16.84%
|
145.19
|
| Gross PPE |
|
197.13
+1.85%
|
193.55
-11.71%
|
219.23
+15.02%
|
190.60
|
| Accumulated Depreciation |
|
-34.72
-34.87%
|
-25.74
+48.09%
|
-49.59
-9.20%
|
-45.41
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
34.18
+12.35%
|
30.42
-26.06%
|
41.14
+34.66%
|
30.55
|
| Other Properties |
|
110.09
-1.19%
|
111.41
-6.24%
|
118.83
-17.81%
|
144.58
|
| Leases |
|
52.86
+2.22%
|
51.72
-12.73%
|
59.26
+283.16%
|
15.47
|
| Goodwill And Other Intangible Assets |
|
20.04
+6.85%
|
18.76
-3.29%
|
19.39
+1.82%
|
19.05
|
| Goodwill |
|
18.79
+7.33%
|
17.51
-3.52%
|
18.14
+1.94%
|
17.80
|
| Other Intangible Assets |
|
1.25
+0.00%
|
1.25
+0.00%
|
1.25
+0.00%
|
1.25
|
| Investments And Advances |
|
271.04
+30.04%
|
208.42
+15.17%
|
180.97
+14.78%
|
157.67
|
| Long Term Equity Investment |
|
0.01
-38.46%
|
0.01
-18.75%
|
0.02
-20.00%
|
0.02
|
| Other Non Current Assets |
|
30.67
-2.93%
|
31.59
+14.70%
|
27.54
+37.62%
|
20.01
|
| Total Liabilities Net Minority Interest |
|
242.85
+2.27%
|
237.46
-2.64%
|
243.91
-1.03%
|
246.44
|
| Current Liabilities |
|
10.59
-30.30%
|
15.20
-1.70%
|
15.46
-9.09%
|
17.01
|
| Payables And Accrued Expenses |
|
10.59
-30.30%
|
15.20
-1.70%
|
15.46
-9.09%
|
17.01
|
| Payables |
|
10.59
-30.30%
|
15.20
-1.70%
|
15.46
-9.09%
|
17.01
|
| Accounts Payable |
|
8.62
+1.63%
|
8.48
-16.35%
|
10.14
+20.46%
|
8.42
|
| Other Payable |
|
0.32
-84.89%
|
2.11
+950.25%
|
0.20
-75.93%
|
0.83
|
| Employee Benefits |
|
80.61
+13.46%
|
71.05
+7.03%
|
66.38
-14.64%
|
77.76
|
| Total Tax Payable |
|
1.65
-64.14%
|
4.60
-10.05%
|
5.12
-34.00%
|
7.75
|
| Income Tax Payable |
|
1.65
-64.14%
|
4.60
-10.05%
|
5.12
-34.00%
|
7.75
|
| Total Non Current Liabilities Net Minority Interest |
|
232.25
+4.49%
|
222.27
-2.71%
|
228.45
-0.43%
|
229.43
|
| Long Term Debt And Capital Lease Obligation |
|
138.33
-1.98%
|
141.12
+0.50%
|
140.41
+1.15%
|
138.81
|
| Long Term Capital Lease Obligation |
|
138.33
-1.98%
|
141.12
+0.50%
|
140.41
+1.15%
|
138.81
|
| Other Non Current Liabilities |
|
13.31
+31.80%
|
10.10
-53.35%
|
21.66
+68.45%
|
12.86
|
| Preferred Securities Outside Stock Equity |
|
—
|
—
|
—
|
—
|
| Stockholders Equity |
|
561.95
+9.82%
|
511.71
+34.23%
|
381.23
+12.94%
|
337.55
|
| Common Stock Equity |
|
561.95
+9.82%
|
511.71
+34.23%
|
381.23
+12.94%
|
337.55
|
| Capital Stock |
|
0.58
+1.39%
|
0.57
+3.05%
|
0.56
+1.27%
|
0.55
|
| Common Stock |
|
0.58
+1.39%
|
0.57
+3.05%
|
0.56
+1.27%
|
0.55
|
| Share Issued |
|
58.28
+1.36%
|
57.49
+3.05%
|
55.79
+1.34%
|
55.05
|
| Ordinary Shares Number |
|
51.03
+0.90%
|
50.57
+2.89%
|
49.16
+0.89%
|
48.72
|
| Treasury Shares Number |
|
7.24
+4.71%
|
6.92
+4.29%
|
6.63
+4.80%
|
6.33
|
| Additional Paid In Capital |
|
992.95
+5.27%
|
943.28
+15.28%
|
818.27
+6.36%
|
769.37
|
| Retained Earnings |
|
-105.81
+18.19%
|
-129.34
+18.24%
|
-158.19
+7.72%
|
-171.42
|
| Gains Losses Not Affecting Retained Earnings |
|
-4.66
+53.55%
|
-10.03
-30.06%
|
-7.71
+28.52%
|
-10.78
|
| Treasury Stock |
|
321.12
+9.68%
|
292.78
+7.76%
|
271.70
+8.61%
|
250.17
|
| Minority Interest |
|
71.89
+13.77%
|
63.19
-43.28%
|
111.42
+24.65%
|
89.39
|
| Other Equity Adjustments |
|
-4.66
+53.55%
|
-10.03
-30.06%
|
-7.71
+28.52%
|
-10.78
|
| Total Equity Gross Minority Interest |
|
633.85
+10.25%
|
574.90
+16.70%
|
492.65
+15.39%
|
426.94
|
| Total Capitalization |
|
561.95
+9.82%
|
511.71
+34.23%
|
381.23
+12.94%
|
337.55
|
| Working Capital |
|
381.94
+3.06%
|
370.59
+14.54%
|
323.54
+2.89%
|
314.46
|
| Invested Capital |
|
561.95
+9.82%
|
511.71
+34.23%
|
381.23
+12.94%
|
337.55
|
| Total Debt |
|
138.33
-1.98%
|
141.12
+0.50%
|
140.41
+1.15%
|
138.81
|
| Capital Lease Obligations |
|
138.33
-1.98%
|
141.12
+0.50%
|
140.41
+1.15%
|
138.81
|
| Net Tangible Assets |
|
541.91
+9.93%
|
492.95
+36.24%
|
361.83
+13.60%
|
318.50
|
| Tangible Book Value |
|
541.91
+9.93%
|
492.95
+36.24%
|
361.83
+13.60%
|
318.50
|
| Available For Sale Securities |
|
271.03
+30.05%
|
208.41
+15.17%
|
180.96
+14.79%
|
157.65
|
| Investmentin Financial Assets |
|
271.03
+30.05%
|
208.41
+15.17%
|
180.96
+14.79%
|
157.65
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-120.44
-224.57%
|
96.69
-43.77%
|
171.96
+178.80%
|
61.68
|
| Cash Flow From Continuing Operating Activities |
|
-120.44
-224.57%
|
96.69
-43.77%
|
171.96
+178.80%
|
61.68
|
| Net Income From Continuing Operations |
|
157.40
-3.31%
|
162.79
+19.17%
|
136.61
-8.61%
|
149.49
|
| Depreciation Amortization Depletion |
|
11.71
+4.88%
|
11.17
+117.21%
|
5.14
-9.26%
|
5.67
|
| Depreciation |
|
—
|
—
|
19.64
+13.19%
|
17.35
|
| Depreciation And Amortization |
|
—
|
—
|
5.14
-9.26%
|
5.67
|
| Other Non Cash Items |
|
5.25
-8.34%
|
5.73
-60.46%
|
14.50
+22.87%
|
11.80
|
| Stock Based Compensation |
|
45.96
-12.12%
|
52.30
+17.61%
|
44.47
-9.90%
|
49.35
|
| Deferred Tax |
|
0.56
+288.89%
|
-0.30
-155.31%
|
0.54
+144.79%
|
-1.20
|
| Deferred Income Tax |
|
0.56
+288.89%
|
-0.30
-155.31%
|
0.54
+144.79%
|
-1.20
|
| Operating Gains Losses |
|
-7.59
+50.51%
|
-15.34
-202.17%
|
-5.08
-119.02%
|
26.69
|
| Gain Loss On Investment Securities |
|
-8.71
+47.46%
|
-16.58
-286.44%
|
-4.29
-117.09%
|
25.11
|
| Net Foreign Currency Exchange Gain Loss |
|
1.12
-9.61%
|
1.24
+257.31%
|
-0.79
-149.59%
|
1.59
|
| Change In Working Capital |
|
-334.82
-182.36%
|
-118.58
-432.73%
|
-22.26
+87.63%
|
-180.00
|
| Change In Receivables |
|
-18.02
+36.34%
|
-28.31
-602.33%
|
-4.03
-128.40%
|
14.20
|
| Changes In Account Receivables |
|
-5.30
+21.34%
|
-6.74
-372.51%
|
-1.43
-109.01%
|
15.83
|
| Change In Payables And Accrued Expense |
|
9.63
-65.52%
|
27.93
+327.18%
|
-12.29
+18.88%
|
-15.15
|
| Change In Accrued Expense |
|
9.56
+104.95%
|
4.67
+141.00%
|
-11.38
-711.26%
|
-1.40
|
| Change In Payable |
|
0.07
-99.72%
|
23.26
+2653.24%
|
-0.91
+93.38%
|
-13.75
|
| Change In Other Working Capital |
|
—
|
—
|
—
|
-1.40
|
| Change In Other Current Assets |
|
-319.53
-216.71%
|
-100.89
-280.32%
|
-26.53
+84.27%
|
-168.66
|
| Change In Other Current Liabilities |
|
-6.90
+60.13%
|
-17.31
-184.04%
|
20.59
+298.35%
|
-10.38
|
| Investing Cash Flow |
|
8.36
+106.98%
|
-119.71
-4.30%
|
-114.78
-3917.36%
|
-2.86
|
| Cash Flow From Continuing Investing Activities |
|
8.36
+106.98%
|
-119.71
-4.30%
|
-114.78
-3917.36%
|
-2.86
|
| Net PPE Purchase And Sale |
|
-5.98
+48.68%
|
-11.65
+79.55%
|
-56.99
-1249.42%
|
-4.22
|
| Purchase Of PPE |
|
-5.98
+48.68%
|
-11.65
+79.55%
|
-56.99
-1249.42%
|
-4.22
|
| Capital Expenditure |
|
-5.98
+48.68%
|
-11.65
+79.55%
|
-56.99
-1249.42%
|
-4.22
|
| Net Investment Purchase And Sale |
|
14.34
+113.27%
|
-108.06
-86.99%
|
-57.79
-4330.60%
|
1.37
|
| Purchase Of Investment |
|
-383.42
+8.15%
|
-417.46
-146.43%
|
-169.40
-16.55%
|
-145.34
|
| Sale Of Investment |
|
397.75
+28.56%
|
309.40
+177.21%
|
111.61
-23.92%
|
146.71
|
| Financing Cash Flow |
|
73.84
+306.43%
|
18.17
+115.26%
|
-119.05
-1426.48%
|
8.97
|
| Cash Flow From Continuing Financing Activities |
|
73.84
+306.43%
|
18.17
+115.26%
|
-119.05
-1426.48%
|
8.97
|
| Net Common Stock Issuance |
|
-28.42
-160.00%
|
47.36
+319.90%
|
-21.54
+19.69%
|
-26.82
|
| Common Stock Payments |
|
-28.42
-34.63%
|
-21.11
+2.00%
|
-21.54
+19.69%
|
-26.82
|
| Common Stock Dividend Paid |
|
-126.92
-6.50%
|
-119.18
-5.99%
|
-112.45
-4.75%
|
-107.35
|
| Cash Dividends Paid |
|
-126.92
-6.50%
|
-119.18
-5.99%
|
-112.45
-4.75%
|
-107.35
|
| Repurchase Of Capital Stock |
|
-28.42
-34.63%
|
-21.11
+2.00%
|
-21.54
+19.69%
|
-26.82
|
| Proceeds From Stock Option Exercised |
|
0.96
-12.64%
|
1.10
+3.48%
|
1.06
+1.92%
|
1.04
|
| Net Other Financing Charges |
|
228.22
+156.74%
|
88.89
+541.02%
|
13.87
-90.24%
|
142.10
|
| Changes In Cash |
|
-38.25
-687.71%
|
-4.86
+92.15%
|
-61.87
-191.25%
|
67.80
|
| Effect Of Exchange Rate Changes |
|
1.69
+206.81%
|
-1.58
-157.51%
|
2.76
+162.07%
|
-4.44
|
| Beginning Cash Position |
|
183.16
-3.40%
|
189.60
-23.77%
|
248.71
+34.18%
|
185.36
|
| End Cash Position |
|
146.60
-19.96%
|
183.16
-3.40%
|
189.60
-23.77%
|
248.71
|
| Free Cash Flow |
|
-126.42
-248.67%
|
85.04
-26.04%
|
114.97
+100.11%
|
57.46
|
| Amortization Of Securities |
|
1.08
+199.72%
|
-1.08
+44.58%
|
-1.95
-1599.13%
|
-0.12
|
| Change In Dividend Payable |
|
0.14
+108.32%
|
-1.66
-196.29%
|
1.72
+197.79%
|
-1.76
|
| Change In Income Tax Payable |
|
-5.06
-3025.93%
|
-0.16
+94.09%
|
-2.74
+81.76%
|
-15.04
|
| Change In Tax Payable |
|
-5.06
-3025.93%
|
-0.16
+94.09%
|
-2.74
+81.76%
|
-15.04
|
| Common Stock Issuance |
|
0.00
-100.00%
|
68.46
|
0.00
|
0.00
|
| Issuance Of Capital Stock |
|
0.00
-100.00%
|
68.46
|
0.00
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-05-04 View
- 10-Q2026-05-01 View
- 8-K2026-04-16 View
- 42026-04-03 View
- 42026-04-03 View
- 42026-04-03 View
- 42026-04-03 View
- 42026-04-03 View
- 42026-04-03 View
- 42026-04-03 View
- 42026-03-23 View
- 42026-03-23 View
- 42026-03-23 View
- 42026-03-23 View
- 42026-03-23 View
- 42026-03-23 View
- 42026-03-23 View
- 42026-03-23 View
- 10-K2026-02-27 View
- 42026-02-12 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|